tiprankstipranks
Bod Science Reports Quarterly Financials Amidst DOCA and Acquisition Progress
Company Announcements

Bod Science Reports Quarterly Financials Amidst DOCA and Acquisition Progress

Story Highlights
  • Bod Science Limited focuses on cannabis drug development and product innovation.
  • The company reports a net cash inflow of $51k and progresses in its acquisition of Biortica.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Invest with Confidence:

Bod Australia Ltd ( (AU:BOD) ) has provided an announcement.

Bod Science Limited, currently under a Deed of Company Arrangement, reported financial activities for the quarter ending December 2024. The company saw a net cash inflow of $51k from operating activities, with customer receipts amounting to $219k. The sale of certain intellectual property assets generated proceeds of $125k. A significant development includes the execution of a binding Share Purchase Agreement with Biortica’s shareholders, contingent upon shareholder approvals and compliance with ASX requirements. The extraordinary general meeting initially scheduled for November 2024 has been postponed to early-to-mid March 2025 due to delays in Biortica’s financial audit. The company’s operations remain supported under the DOCA, with Biortica funding ongoing trading costs.

More about Bod Australia Ltd

Bod Science Limited is a cannabis-focused drug development and product innovation company. It aims to progress research and development with a clear clinical trial pathway to commercialize premium, scientifically proven products for both patients and consumers. The company has established partnerships with large corporate entities and collaborations with leading research organizations to advance the use of cannabis-related medicines for therapeutic purposes.

YTD Price Performance: 20.0%

Technical Sentiment Consensus Rating: Buy

Current Market Cap: A$4.26M

See more insights into BOD stock on TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App